Hostname: page-component-669899f699-chc8l Total loading time: 0 Render date: 2025-04-24T12:39:32.019Z Has data issue: false hasContentIssue false

Impact of omega-3 fatty acid supplementation on clinical manifestations in autism spectrum disorders: an umbrella review of meta-analyses

Published online by Cambridge University Press:  21 November 2024

Hamid Abbasi
Affiliation:
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran Neurosciences Research Center (NSRC), Tabriz University of Medical Sciences, Tabriz, Iran
Abdolrahman Parhiz
Affiliation:
PhD Student of Educational Measurement and Evaluation, Kish International Campus, University of Tehran, Tehran, Iran
Sara Khoshdooz
Affiliation:
Faculty of Medicine, Guilan University of Medical Science, Rasht, Iran
Farnush Bakhshimoghaddam
Affiliation:
Department of Nutrition, School of Allied Medical Sciences, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Saeid Doaei*
Affiliation:
Department of Community Nutrition, Faculty of Nutrition and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran Reproductive Health Research Center, Department of Obstetrics and Gynecology, School of Medicine, Al-Zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran
Maryam Gholamalizadeh
Affiliation:
Cancer research center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
*
Corresponding author: Saeid Doaei; Email: [email protected]

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental condition. Omega-3 fatty acid insufficiency has been linked to ASD. This umbrella meta-analysis was performed to investigate the effects of omega-3 supplementation on clinical manifestations in participants with ASD. Based on the PRISMA statement, databases including Web of Science, PubMed and Scopus were systematically searched for published meta-analyses on the effect of omega-3 supplementation on ASD up to December 2023. To assess the risk of bias, the assessment of multiple systematic reviews (AMSTAR)-2 was utilised. The outcomes were core and non-core symptoms of ASD including social withdrawal/lethargy, cluttering speech, hyperactivity, irritability and stereotypy. Seven meta-analyses eventually remained in the umbrella review. The results revealed that omega-3 fatty acid supplementation caused a significant reduction in cluttering speech in studies conducted on age ≤8 years (effect size (ES) −0·30; 95% confidence interval (CI) −0·55, −0·06; P = 0·02). Omega-3 supplementation caused a significant reduction in hyperactivity in participants ≤8 years (ES −0·30; 95% CI −0·55, −0·06; P = 0·02) and in participants who received the supplements for more than 14 weeks (ES −0·30; 95% CI −0·55, −0·06; P = 0·02). A dosage of ≤1000 mg/d of omega-3 supplementation led to a significant increase in the stereotypy/restricted and repetitive interests and behaviours (ES 0·19; 95% CI 0·03, 0·35; P = 0·02). This umbrella review revealed that omega-3 fatty acid may be a beneficial supplement to control cluttering speech and hyperactivity in children with ASD who are 8 years old or younger.

Type
Review Article
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Nutrition Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Lord, C, Cook, EH, Leventhal, BL & Amaral, DG (2000) Autism spectrum disorders. Neuron 28, 355363.Google Scholar
Rfat, M, Koçak, O & Uzun, B (2023) Parenting challenges in families of children with a diagnosis of autism spectrum disorder: a qualitative research study in Istanbul. Global Soc Welfare 7, 110.Google Scholar
Zeidan, J, Fombonne, E, Scorah, J, Ibrahim, A, Durkin, MS, Saxena, S, et al. (2022) Global prevalence of autism: sa systematic review update. Autism Res 15, 778790.Google Scholar
Thapar, A, Fowler, T, Rice, F, Scourfield, J, Van Den Bree, M, Thomas, H, et al. Maternal smoking during pregnancy and attention deficit hyperactivity disorder symptoms in offspring. Am J Psychiatry 160, 19851989.Google Scholar
Banderali, G, Martelli, A, Landi, M, Moretti, F, Betti, F, Radaelli, G, et al. (2015) Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. J Transl Med 13, 17.Google Scholar
Rumrich, IK, Vähäkangas, K, Viluksela, M & Hänninen, O (2020) Chained risk assessment for life-long disease burden of early exposures–demonstration of concept using prenatal maternal smoking. Int J Environ Res Public Health 17, 1472.Google Scholar
Jaitner, A, Vaudel, M, Tsaneva-Atanasova, K, Njølstad, PR, Jacobsson, B, Bowden, J, et al. (2024) Smoking during pregnancy and its effect on placental weight: a Mendelian randomization study. BMC Pregnancy Childbirth 24, 238.Google Scholar
Fu, JM, Satterstrom, FK, Peng, M, Brand, H, Collins, RL, Dong, S, et al. (2022) Rare coding variation provides insight into the genetic architecture and phenotypic context of autism. Nat Genet 54, 13201331.Google Scholar
Shiani, A, Sharafi, K, Omer, AK, Kiani, A, Karamimatin, B, Massahi, T, et al. (2022) A systematic literature review on the association between exposures to toxic elements and an autism spectrum disorder. Science Total Environ 857, 159246.Google Scholar
Sierra-Arregui, T, Llorente, J, Minguez, PG, Tønnesen, J & Peñagarikano, O (2020) Neurobiological mechanisms of autism spectrum disorder and epilepsy, insights from animal models. Neuroscience 445, 6982.Google Scholar
Rodop, BB, Başkaya, E, Altuntaş, İ & Erbaş, O (2021) Nutrition effect on autism spectrum disorders. J Exp Basic Med Sci 2, 007017.Google Scholar
Crump, C, Sundquist, J & Sundquist, K (2021) Preterm or early term birth and risk of autism. Pediatrics 148, 121.Google Scholar
Karhu, E, Zukerman, R, Eshraghi, RS, Mittal, J, Deth, RC, Castejon, AM, et al. (2020) Nutritional interventions for autism spectrum disorder. Nutr Rev 78, 515531.Google Scholar
Jiang, Y, Dang, W, Nie, H, Kong, X, Jiang, Z & Guo, J (2023) Omega-3 polyunsaturated fatty acids and/or vitamin D in autism spectrum disorders: a systematic review. Front Psychiatry 14, 126.Google Scholar
Martins, BP, Bandarra, NM & Figueiredo-Braga, M (2020) The role of marine omega-3 in human neurodevelopment, including autism spectrum disorders and attention-deficit/hyperactivity disorder – a review. Crit Rev Food Sci Nutr 60, 14311446.Google Scholar
Gorji, A (2022) Neuroinflammation: The pathogenic mechanism of neurological disorders. Basel, Switzerland: MDPI, p. 5744.Google Scholar
Kerdiles, O, Layé, S & Calon, F (2017) Omega-3 polyunsaturated fatty acids and brain health: preclinical evidence for the prevention of neurodegenerative diseases. Trends Food Sci Technol 69, 203213.Google Scholar
Bell, J, MacKinlay, E, Dick, J, MacDonald, D, Boyle, R & Glen, A (2004) Essential fatty acids and phospholipase A2 in autistic spectrum disorders. Prostaglandins, Leukotrienes Essential Fatty Acids 71, 201204.Google Scholar
Vancassel, S, Durand, G, Barthelemy, C, Lejeune, B, Martineau, J, Guilloteau, D, et al. (2001) Plasma fatty acid levels in autistic children. Prostaglandins, Leukotrienes Essential Fatty Acids (PLEFA) 65, 17.Google Scholar
Amminger, GP, Berger, GE, Schäfer, MR, Klier, C, Friedrich, MH & Feucht, M (2007) Omega-3 fatty acids supplementation in children with autism: a double-blind randomized, placebo-controlled pilot study. Biol Psychiatry 61, 551553.Google Scholar
Agostoni, C, Nobile, M, Ciappolino, V, Delvecchio, G, Tesei, A, Turolo, S, et al. (2017) The role of omega-3 fatty acids in developmental psychopathology: a systematic review on early psychosis, autism, and ADHD. Int J Mol Sci 18, 2608.Google Scholar
Mazahery, H, Stonehouse, W, Delshad, M, Kruger, MC, Conlon, CA, Beck, KL, et al. (2017) Relationship between long chain n-3 polyunsaturated fatty acids and autism spectrum disorder: systematic review and meta-analysis of case-control and randomised controlled trials. Nutrients 9, 155.Google Scholar
Le Roux, C (2015) Use of omega-3 for improving behavioural outcomes in autism spectrum disorder in children: a review of the literature. Austr J Herbal Med 27, 105110.Google Scholar
Bent, S, Bertoglio, K, Ashwood, P, Bostrom, A & Hendren, RL (2011) A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disorders 41, 545554.Google Scholar
Bent, S, Hendren, RL, Zandi, T, Law, K, Choi, J-E, Widjaja, F, et al. (2014) Internet-based, randomized, controlled trial of omega-3 fatty acids for hyperactivity in autism. J Am Acad Child Adolesc Psychiatry 53, 658666.Google Scholar
Cheng, Y-S, Tseng, P-T, Chen, Y-W, Stubbs, B, Yang, W-C, Chen, T-Y, et al. (2017) Supplementation of omega 3 fatty acids may improve hyperactivity, lethargy, and stereotypy in children with autism spectrum disorders: a meta-analysis of randomized controlled trials. Neuropsychiatr Dis Treat 4, 25312543.Google Scholar
Voigt, RG, Mellon, MW, Katusic, SK, Weaver, AL, Matern, D, Mellon, B, et al. (2014) Dietary docosahexaenoic acid supplementation in children with autism. J Pediatr Gastroenterol Nutr 58, 715722.Google Scholar
Doaei, S, Bourbour, F, Teymoori, Z, Jafari, F, Kalantari, N, Torki, SA, et al. (2021) The effect of omega-3 fatty acids supplementation on social and behavioral disorders of children with autism: a randomized clinical trial. Pediatr Endocrinol Diabetes Metab 27, 1218.Google Scholar
de Andrade Wobido, K, de Sá Barreto da Cunha, M, Miranda, SS, da Mota Santana, J, da Silva, DCG & Pereira, M (2022) Non-specific effect of omega-3 fatty acid supplementation on autistic spectrum disorder: systematic review and meta-analysis. Nutr Neurosci 25, 19952007.Google Scholar
Moher, D, Liberati, A, Tetzlaff, J & Altman, DG (2009) Group* P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Internal Med 151, 264269.Google Scholar
Shea, BJ, Reeves, BC, Wells, G, Thuku, M, Hamel, C, Moran, J, et al. (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 358, 18.Google Scholar
Higgins, JP, Altman, DG, Gøtzsche, PC, Jüni, P, Moher, D, Oxman, AD, et al. (2011) The Cochrane collaboration’s tool for assessing risk of trials. BMJ 11, 343351.Google Scholar
Begg, CB & Mazumdar, M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 088101.Google Scholar
Egger, M, Smith, GD, Schneider, M & Minder, C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629634.Google Scholar
Bent, S, Bertoglio, K & Hendren, RL (2009) Omega-3 fatty acids for autistic spectrum disorder: a systematic review. J Autism Dev Disorders 39, 11451154.Google Scholar
Donovan, S, Dewey, K, Novotny, R, Stang, J, Taveras, E, Kleinman, R, et al. (2022) Omega-3 fatty acids from supplements consumed before and during pregnancy and lactation and developmental milestones, including neurocognitive development, in the child: a systematic review. Alexandria, VA: USDA Nutrition Evidence Systematic Review; 2020 Jul. PMID: 35289988.Google Scholar
de Pablo, GS, Jordá, CP, Vaquerizo-Serrano, J, Moreno, C, Cabras, A, Arango, C, et al. (2023) Systematic review and meta-analysis: efficacy of pharmacological interventions for irritability and emotional dysregulation in autism spectrum disorder and predictors of response. J Am Acad Child Adolesc Psychiatry 62, 151168.Google Scholar
De Crescenzo, F, D’Alò, GL, Morgano, GP, Minozzi, S, Mitrova, Z, Saulle, R, et al. (2020) Impact of polyunsaturated fatty acids on patient-important outcomes in children and adolescents with autism spectrum disorder: a systematic review. Health Qual Life Outcomes 18, 112.Google Scholar
Colak, H, Sariyer, ET & Nogay, NH (2023) The effect of nutritional interventions reducing oxidative stress on behavioural and gastrointestinal problems in autism spectrum disorder. Int J Dev Neurosci 83, 135164.Google Scholar
Li, Y-J, Li, Y-M & Xiang, D-X (2018) Supplement intervention associated with nutritional deficiencies in autism spectrum disorders: a systematic review. Eur J Nutr 57, 25712582.Google Scholar
James, S, Montgomery, P & Williams, K (2011) Omega-3 fatty acids supplementation for autism spectrum disorders (ASD). Cochrane Database Syst Rev 11, CD007992.Google Scholar
Zhou, MS, Nasir, M, Farhat, LC, Kook, M, Artukoglu, BB & Bloch, MH (2021) Meta-analysis: pharmacologic treatment of restricted and repetitive behaviors in autism spectrum disorders. J Am Acad Child Adolesc Psychiatry 60, 3545.Google Scholar
Horvath, A, Łukasik, J & Szajewska, H (2017) ω-3 fatty acid supplementation does not affect autism spectrum disorder in children: a systematic review and meta-analysis. J Nutr 147, 367376.Google Scholar
Fraguas, D, Díaz-Caneja, CM, Pina-Camacho, L, Moreno, C, Duran-Cutilla, M, Ayora, M, et al. (2019) Dietary interventions for autism spectrum disorder: a meta-analysis. Pediatrics 144, e20183218.Google Scholar
Louis, KOS & Schulte, K (2011) Defining cluttering: The lowest common denominator. Cluttering: Psychology Press. 233253.Google Scholar
Góral-Półrola, J, Zielińska, J, Jastrzebowska, G & Tarkowski, Z (2016) Cluttering: specific communication disorder. Acta Neuropsychologica 14, 115.Google Scholar
Díaz Vargas, D & Leonario Rodríguez, M (2022) Effectiveness of nutritional interventions on behavioral symptomatology of autism spectrum disorder: a systematic review. Nutr Hosp 39, 13781388.Google Scholar
Rong, Y, Yang, C-J, Jin, Y & Wang, Y (2021) Prevalence of attention-deficit/hyperactivity disorder in individuals with autism spectrum disorder: a meta-analysis. Res Autism Spect Disorders 83, 101759.Google Scholar
Vecchione, R, Vigna, C, Whitman, C, Kauffman, EM, Braun, JM, Chen, A, et al. (2021) The association between maternal prenatal fish intake and child autism-related traits in the EARLI and HOME Studies. J Autism Dev Disorders 51, 487500.Google Scholar
Bos, DJ, van Montfort, SJ, Oranje, B, Durston, S & Smeets, PA (2016) Effects of omega-3 polyunsaturated fatty acids on human brain morphology and function: what is the evidence? Eur Neuropsychopharmacol 26, 546561.Google Scholar